Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:681612.
doi: 10.1155/2015/681612. Epub 2015 Apr 8.

Adipokines as drug targets in diabetes and underlying disturbances

Affiliations
Review

Adipokines as drug targets in diabetes and underlying disturbances

Vinícius Andrade-Oliveira et al. J Diabetes Res. 2015.

Abstract

Diabetes and obesity are worldwide health problems. White fat dynamically participates in hormonal and inflammatory regulation. White adipose tissue is recognized as a multifactorial organ that secretes several adipose-derived factors that have been collectively termed "adipokines." Adipokines are pleiotropic molecules that gather factors such as leptin, adiponectin, visfatin, apelin, vaspin, hepcidin, RBP4, and inflammatory cytokines, including TNF and IL-1β, among others. Multiple roles in metabolic and inflammatory responses have been assigned to these molecules. Several adipokines contribute to the self-styled "low-grade inflammatory state" of obese and insulin-resistant subjects, inducing the accumulation of metabolic anomalies within these individuals, including autoimmune and inflammatory diseases. Thus, adipokines are an interesting drug target to treat autoimmune diseases, obesity, insulin resistance, and adipose tissue inflammation. The aim of this review is to present an overview of the roles of adipokines in different immune and nonimmune cells, which will contribute to diabetes as well as to adipose tissue inflammation and insulin resistance development. We describe how adipokines regulate inflammation in these diseases and their therapeutic implications. We also survey current attempts to exploit adipokines for clinical applications, which hold potential as novel approaches to drug development in several immune-mediated diseases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The adipose tissue secretes molecules called adipokines. These adipokines act locally (adipose tissue) and systemically, regulating several aspects of body homeostasis, including the immune system, the cardiovascular system, and insulin sensitivity.
Figure 2
Figure 2
The adipose tissue secretes several hormone-like molecules called adipokines. Adipokines are pleiotropic molecules, participating in body physiology regulation. Adipokines also play a role in several diseases such as diabetes, atherosclerosis, and autoimmune diseases, among others.

References

    1. Guh D. P., Zhang W., Bansback N., Amarsi Z., Birmingham C. L., Anis A. H. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9, article 88 doi: 10.1186/1471-2458-9-88. - DOI - PMC - PubMed
    1. Sauvanet J. P. Congress of the International Diabetes Federation (IDF-Paris 2003) La Presse Médicale. 2003;32:1864–1868. - PubMed
    1. Ratner R. E. Type 2 diabetes mellitus: the grand overview. Diabetic Medicine. 1998;15(supplement 4):S4–S7. - PubMed
    1. Moraes-Vieira P. M. M., Bassi Ê. J., Araujo R. C., Câmara N. O. S. Leptin as a link between the immune system and kidney-related diseases: leading actor or just a coadjuvant? Obesity Reviews. 2012;13(8):733–743. doi: 10.1111/j.1467-789x.2012.00997.x. - DOI - PubMed
    1. Kershaw E. E., Flier J. S. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2548–2556. doi: 10.1210/jc.2004-0395. - DOI - PubMed

Publication types

LinkOut - more resources